Development of autoimmune hepatitis in primary biliary cirrhosis

Liver International

Volumn 27, Issue 8, 2007, Pages 1086-1090

  Gossard, Andrea A ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune hepatitis superimposed on primary biliary cirrhosis; Sequentialdevelopment of autoimmune hepatitis in PBC; Treatmentof autoimmune hepatitis developing in patients with PBC

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; PREDNISONE; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER BIOPSY; PRIMARY BILIARY CIRRHOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; ALANINE TRANSAMINASE; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; AZATHIOPRINE; CHOLAGOGUES AND CHOLERETICS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 34548630561     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01538.x     Document Type: Article

References (13)

1. Heathcote J. Primary biliary cirrhosis. In: Al Knawy B, Shiffman ML, Wiesner RH, eds. Hepatology: A Practical Approach. Philadelphia: Elsevier, 2004; 249-58.
2. Mahl T, Schockcor W, Boyer JL. Primary biliary cirrhosis: Survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994; 20: 707.
3. Kanda T, Yokosuka O, Hirasawa Y, et al. Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: Report of two cases. Dig Dis Sci 2006; 51: 45-6.
4. Poupon RE, Lindor KD, Cauch-Dudek K. Combined analysis of randomized controlled trials of UDCA in PBC. Gastroenterology 1997; 113: 1264-9.
5. Pares A, Caballeria L, Rhodes J. Excellent long term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2005; 130: 715-20.
6. Corpechot C, Carrat F, Bahr A, et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005; 128: 297-303.
7. Czaja A. Autoimmune hepatitis. In: Feldman M, Friedman LS, Sleisenger MH, eds. Gastrointestinal and Liver Disease. Philadelphia: WB Saunders, 2002; 1462-73.
8. Patal N, Amarapurkar D, Amaraparkar A. Primary biliary cirrhosis and autoimmune hepatitis switch over: Report of 2 cases. Trop Gastroenterol 2005; 26: 136-8.
9. Weyman RL, Voigt M. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: A case report and review of the literature. Am J Gastroentol 2001; 96: 585-7.
10. Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999; 29: 1078-84.
11. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1999; 28: 296-301.
12. Angulo P, El-Amin O, Carpenter HA, Lindor KD. Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis. Am J Gastroenterol 2001; 96: 3021-7.
13. Colombato LA, Alvarez F, Cote J, Huet PM. Autoimmune cholangiopathy: The result of consecutive primary biliary cirrhosis and autoimmune hepatitis. Gastroenterology 1994; 107: 1839-43.